| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966662 | Vaccine | 2014 | 5 Pages |
Abstract
The current assignment of an anti-Vi IgG protective level may be of value when evaluating vaccine performance of future Vi conjugate vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shousun C. Szu, Keith P. Klugman, Steven Hunt,